Clinical Data

theatre stage with red curtains
Biotech

Novartis’ phase 3 wins in Sjögren's see high placebo effect

Novartis is pulling back the curtain on late-stage Sjögren's wins, revealing an edge over placebo in both studies.
Gabrielle Masson Oct 29, 2025 12:03pm
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Kyverna links CAR-T to autoimmune improvements in small trial

Oct 29, 2025 10:00am
Sketch of lungs

Edesa claims survival win for phase 3 respiratory failure trial

Oct 28, 2025 9:45am
decision path change of plans arrows business decision

Aldeyra drops and swaps RASP assets in response to data

Oct 28, 2025 9:10am
hurdles

BridgeBio aces phase 3 rare disease test, clearing path to FDA

Oct 27, 2025 7:00am
Wall Street IPO initial public offering markets shares stock

Arcturus' stock halves on cystic fibrosis readout

Oct 22, 2025 1:01pm